Our study confirmed previous reports of the existence of dyslipidemia (enhanced TG, TC, LDL-C, apoB, Lp(a), apoCIII and lower HDL-C and apoAI) and inflammation (increased TNF-α and hs-CRP) in CHD patients [15, 16]. Here, APOC3 is linked to metabolic syndrome.